Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients
Hoshikawa, Kohei, Naito, Takafumi, Akutsu, Shunta, Saotome, Masao, Maekawa, Yuichiro, Kawakami, JunichiLanguage:
english
Journal:
Basic & Clinical Pharmacology & Toxicology
DOI:
10.1111/bcpt.13355
Date:
October, 2019
File:
PDF, 20.68 MB
english, 2019